Paclitaxel Suppress Dedifferentiation via Mitogen-activated Protein Kinase Pathway in Rabbit Articular Chondrocyte

  • Im, Jeong-Hee (Department of Biological Sciences, College of Natural Sciences, Kongju National University) ;
  • Kim, Song-Ja (Department of Biological Sciences, College of Natural Sciences, Kongju National University)
  • ;
  • 김송자 (국립공주대학교 자연과학대학 생명과학과)
  • Published : 2009.03.31

Abstract

Microtubule-interfering agents (MIAs), including paclitaxel, have been attributed in part to interference with microtubule assembly, impairment of mitosis, and changes in cytoskeleton. But the signaling mechanisms that link microtubule disarray to destructive or protective cellular responses are poorly understood. This study investigated the effect of paclitaxel on differentiation such as type II collagen expression and sulfated proteoglycan accumulation in rabbit articular chondrocytes. Paclitaxel caused differentiated chondrocyte phenotype as demonstrated by increment of type II collagen expression and proteoglycan synthesis Paclitaxel treatment stimulated activation of ERK-1/2 and p38 kinase. Inhibition of ERK-1/2 with PD98059 enhanced paclitaxel-induced differentiation, whereas inhibition of p38 kinase with SB203580 suppressed paclitaxel-induced differentiation. Our findings suggest that ERK-1/2 and p38 kinase oppositely regulate paclitaxel-induced differentiation in chondrocytes.

Keywords

References

  1. Amin AR, Abramson SB. The role of nitric oxide in articular cartilage breakdown in osteoarthritis. Curr Opin Rheumatol. 1998. 10: 263-268. https://doi.org/10.1097/00002281-199805000-00018
  2. Arnal I, Wade RH. How does taxol stabilize microtubules- Curr Biol. 1995. 5: 900-908. https://doi.org/10.1016/S0960-9822(95)00180-1
  3. Brahn E, Tang C, Banquerigo ML. Regression of collagen-induced arthritis with taxol, a microtubule stabilizer. Arthritis Rheum. 1994. 37: 839-845. https://doi.org/10.1002/art.1780370611
  4. Brown PD, Benya PD. Alterations in chondrocyte cytoskeletal architecture during phenotypic modulation by retinoic acid and dihydrocytochalasin B-induced reexpression. J Cell Biol. 1988. 106: 171-179. https://doi.org/10.1083/jcb.106.1.171
  5. Cash DE, Bock CB, Schughart K, Linney E, Underhill TM. Retinoic acid receptor alpha function in vertebrate limb skeletogenesis: a modulator of chondrogenesis. J Cell Biol. 1997. 136: 445-457. https://doi.org/10.1083/jcb.136.2.445
  6. Cohen E, Ophir I, Shaul YB. Induced differentiation in HT29, a human colon adenocarcinoma cell line. J Cell Sci. 1999. 112: 2657-2666.
  7. DeLise AM, Fischer L, Tuan RS. Cellular interaction and signaling in cartilage development. Osteoarthr Cart. 2000. 8: 309-334. https://doi.org/10.1053/joca.1999.0306
  8. Fukui N, Purple CR, Sandell LJ. Cell biology of osteoarthritis: the chondrocyte's response to injury. Crru Rheumatol Rep. 2001. 3: 496-505. https://doi.org/10.1007/s11926-001-0064-8
  9. Hui A, Min WX, Tang J, Cruz TF. Inhibition of activator protein 1 activity by paclitaxel suppresses interleukin-1-induced collagenase and stromelysin expression by bovine chondrocytes. Arthritis Rheum. 1998. 41: 869-876. https://doi.org/10.1002/1529-0131(199805)41:5<869::AID-ART15>3.0.CO;2-3
  10. Horwitz SB. Mechanism of action of taxol. Trends Pharmacol Sci. 1992. 13: 134-136. https://doi.org/10.1016/0165-6147(92)90048-B
  11. Houri JM, O'Sullivan FX. Animal models in rheumatoid arthritis. Curr Opin Rheumatol. 1995. 7: 201-205. https://doi.org/10.1097/00002281-199505000-00008
  12. Kim SJ, Ju JW, Oh CD, Yoon YM, Song WK, Kim JH, Yoo YJ, Bang OS, Kang SS, Chun JS. ERK-1/2 and p38 kinase oppositely regulate nitric oxide-induced apoptosis of chondrocytes in association with p53, caspase-3, and differentiation status. J Biol Chem. 2002. 277: 1332-1339. https://doi.org/10.1074/jbc.M107231200
  13. Lefebvre V, Peeters-Joris C, Vaes G. Production of collagens, collagenase and collagenase inhibitor during the dedifferentiation of articular chondrocytes by serial subcultures. Biochim Biophys Acta. 1990. 1051: 266-275. https://doi.org/10.1016/0167-4889(90)90132-W
  14. Martel-pelletier J, Alaaeddine N, Pelletier JP. Cytokines and their role in the pathophysiology of osteoarthritis. Front. Biosci. 1999. 4. 694-703. https://doi.org/10.2741/Martel
  15. Sandell LJ, Aigner T. Articular cartilage and changes in arthritis. An introduction: cell biology of asteoarthritis. Arthr. Res. 2001. 3: 107-113. https://doi.org/10.1186/ar148
  16. Subbaramaiah K, Hart JC, Norton L, Dannenberg AJ. Microtubuleinterfering agents stimulate the transcription of cyclooxygenase-2. Evidence for involvement of ERK1/2 and p38 mitogenactivated protein kinase pathways. J Biol Chem. 2000. 275: 14838-14845. https://doi.org/10.1074/jbc.275.20.14838
  17. Wani MC, Taylor HL, Wall ME, Coggon P, McPhail AT. Plant antitumor agents. V.I. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J Am Chem Soc. 1971. 93: 2325-2327. https://doi.org/10.1021/ja00738a045
  18. Wiernik PH, Schwartz EL, Strauman JJ, Dutcher JP, Lipton RB, Paietta E. Phase I clinical and pharmacokinetic study of taxol. Cancer Res. 1987. 47: 2486-2493.
  19. Yoon YM, Kim SJ, Oh CD, Ju JW, Song WK, Yoo YJ, Huh TL, Chun JS. Maintenance of differentiated phenotype of articular chondrocytes by protein kinase C and extracellular signalregulated protein kinase. J Biol Chem. 2002. 277: 8412-8420. https://doi.org/10.1074/jbc.M110608200
  20. Vinall RL, Lo SH, Reddi AH. Regulation of articular chondrocyte phenotype by bone morphogenetic protein 7, interleukin 1, and cellular context is dependent on the cytoskeleton. Exp Cell Res. 2002. 272: 32-44. https://doi.org/10.1006/excr.2001.5395